The European Commission welcomes the political agreement reached between the European Parliament and the Council on the Critical Medicines Act.
This landmark agreement will help strengthen the resilience of Europe’s pharmaceutical supply chains, reduce dependencies on single suppliers, and improve the availability of critical medicines for patients across the EU.
Key elements of the agreement include:
🔹 Stronger diversification and resilience requirements in public procurement
🔹 Support for EU manufacturing capacity through Strategic Projects
🔹 Enhanced cooperation and solidarity between Member States during shortages
🔹 Collaborative procurement to improve access to medicines across Europe
🔹 Stronger international partnerships to secure supply chains
Together with the recently agreed pharmaceutical reform, the Critical Medicines Act will help build a stronger and more resilient European Health Union.
Link to Press Release – https://lnkd.in/e-ZFSdWc